<?xml version="1.0" encoding="UTF-8"?>
<p>Thus, the patients were able to be divided into three final study groupsâ€”group 1: patients with HIV in regular treatment with ARVT; group 2: patients with HIV without regular treatment with ARVT; group 3: control patients.</p>
